For the Culture By The Culture. ISSN: 3064-9331.
France keeps extending medical cannabis access while politically resisting broader legalization. Pot Culture Magazine examines the country’s cautious framework, frozen patient access, regulatory delays, and the growing contradiction between public rhetoric and the reality of cannabis reform already unfolding inside France.
The lazy stoner stereotype was never science. Cannabis can impair performance, and heavy use can cause real problems, but global data, workplace research, motivation studies, and impairment science do not support treating every cannabis user as lazy, unsafe, or broken. Cannabis Lies Vol. 12 separates real risk from recycled prohibition propaganda.
The federal move to Schedule III is a masterclass in bureaucratic maintenance. While corporations celebrate tax relief, the core structure of the drug war remains untouched. This analysis deconstructs the Reform Lie, exposing how the state uses symbolic gestures to professionalize a privilege for the few while keeping the machinery of punishment active for everyone else.
Workplace Wars continues in New Jersey, where Senate Bill S3452 would protect registered medical cannabis patients from metabolite-only drug test punishment. The proposal shifts the burden to employers, requiring proof by a preponderance of the evidence that lawful medical use caused on-duty impairment, backed by specific articulable symptoms. It also keeps the written notice and three-day explanation or retest process.
A hard edged remembrance of Hunter S. Thompson that treats Gonzo as method, not costume, then drags that standard into the modern weed era. From political press pack corruption to the hypocrisy baked into cannabis legislation, this piece calls out the polite liars, the soft coverage, and the institutions that criminalized millions before trying to profit from “progress.”
Actor David Krumholtz’s experience with Cannabinoid Hyperemesis Syndrome sparked a backlash that reveals a deeper problem in cannabis culture. This piece examines how rare conditions get weaponized, why defensive reactions backfire, and how patients, veterans, and families are erased when nuance collapses on both sides of the cannabis debate.